Market Cap 145.96B
Revenue (ttm) 22.60B
Net Income (ttm) 2.99B
EPS (ttm) N/A
PE Ratio 29.81
Forward PE 28.38
Profit Margin 13.25%
Debt to Equity Ratio 0.78
Volume 1,179,928
Avg Vol 1,306,410
Day's Range N/A - N/A
Shares Out 382.31M
Stochastic %K 62%
Beta 0.94
Analysts Strong Sell
Price Target $434.56

Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the t...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
patrickhuxley
patrickhuxley Oct. 27 at 8:56 PM
$LOW $SYK Locked chips https://stocktwits.com/jacobvirginia2/message/633847328
0 · Reply
OliviaAte
OliviaAte Oct. 27 at 4:57 PM
0 · Reply
primohaywood
primohaywood Oct. 26 at 5:38 PM
$LOW $SYK Gap filling https://stocktwits.com/colindequincey/message/633715093
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Oct. 24 at 5:21 PM
$SYK holding since 2022 💪💪💪
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 10:42 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $12.10 - $13.60 Take Profit: $27.59 Stop Bleeding: $10.65 ROI Potential: 128% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 4:59 PM
Barclays has adjusted their stance on Stryker ( $SYK ), setting the rating to Overweight with a target price of 443 → 453.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 22 at 2:18 PM
$SYK RSI: 69.98, MACD: 0.6836 Vol: 6.26, MA20: 370.99, MA50: 378.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:01 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $11.40 - $11.50 Take Profit: $22.31 Stop Bleeding: $10.12 ROI Potential: 94% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 4:57 PM
3 wide-moat winners to watch for Q4 🔥 $MCO, $SYK and $CBRE are spotlighted for their strong growth forecasts and strategic expansions — a combo that could strengthen any portfolio’s resilience this quarter. See why these names could enhance Q4 returns 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-teaser-16944&ADID=SYND_STOCKTWITS_TWEET_2_2772986_TEASER_16944
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 2:06 PM
Why $MCO, $SYK, & $CBRE are top Wide Moat picks! 🏰 Moody's, Stryker, and CBRE each boast a Zacks Rank #2 (Buy) for the current quarter, highlighting their strategic advantages and resilience. With strong growth drivers—like MCO's acquisitions, SYK's product innovation, and CBRE's diversified model—these stocks are well-positioned for sustained performance. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-body-16864&ADID=SYND_STOCKTWITS_TWEET_2_2772986_BODY_16864
0 · Reply
Latest News on SYK
Stryker Launches Incompass Total Ankle System at AOFAS 2025

Sep 9, 2025, 7:20 AM EDT - 6 weeks ago

Stryker Launches Incompass Total Ankle System at AOFAS 2025


Stryker Q2: Record Mako Installation And High Utilization

Aug 19, 2025, 2:55 PM EDT - 2 months ago

Stryker Q2: Record Mako Installation And High Utilization


Stryker to host investor day

Aug 15, 2025, 8:00 AM EDT - 2 months ago

Stryker to host investor day


Stryker declares an $0.84 per share quarterly dividend

Aug 7, 2025, 8:00 AM EDT - 2 months ago

Stryker declares an $0.84 per share quarterly dividend


Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:59 PM EDT - 3 months ago

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript


Stryker reports second quarter 2025 operating results

Jul 31, 2025, 4:05 PM EDT - 3 months ago

Stryker reports second quarter 2025 operating results


The Big 3: NXT, ANET, SYK

Jun 26, 2025, 1:01 PM EDT - 4 months ago

The Big 3: NXT, ANET, SYK

ANET NXT


Stryker receives FDA clearance for Incompass Total Ankle System

Jun 25, 2025, 8:15 AM EDT - 4 months ago

Stryker receives FDA clearance for Incompass Total Ankle System


The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

Jun 3, 2025, 11:09 AM EDT - 5 months ago

The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

MA NFLX


Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:28 PM EDT - 6 months ago

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript


Stryker reports first quarter 2025 operating results

May 1, 2025, 4:05 PM EDT - 6 months ago

Stryker reports first quarter 2025 operating results


Stryker completes sale of U.S. spinal implants business

Apr 1, 2025, 4:05 PM EDT - 7 months ago

Stryker completes sale of U.S. spinal implants business


Stryker announces Annual Meeting of Shareholders

Mar 25, 2025, 4:15 PM EDT - 7 months ago

Stryker announces Annual Meeting of Shareholders


The Big 3: MMM, PM, SYK

Mar 18, 2025, 1:01 PM EDT - 7 months ago

The Big 3: MMM, PM, SYK

MMM PM


Stryker launches Steri-Shield 8 personal protection system

Mar 4, 2025, 8:07 AM EST - 8 months ago

Stryker launches Steri-Shield 8 personal protection system


Stryker launches Sync Badge

Mar 3, 2025, 8:07 AM EST - 8 months ago

Stryker launches Sync Badge


The Big 3: FTNT, NXT, SYK

Feb 20, 2025, 12:14 PM EST - 8 months ago

The Big 3: FTNT, NXT, SYK

FTNT NXT


Kadant Set to Join S&P SmallCap 600

Feb 13, 2025, 5:54 PM EST - 9 months ago

Kadant Set to Join S&P SmallCap 600

KAI


Sales Growth, Strategic Acquisitions Drive Stryker Higher

Jan 31, 2025, 4:34 PM EST - 9 months ago

Sales Growth, Strategic Acquisitions Drive Stryker Higher


Overlooked Stock: SYK

Jan 28, 2025, 4:45 PM EST - 9 months ago

Overlooked Stock: SYK


patrickhuxley
patrickhuxley Oct. 27 at 8:56 PM
$LOW $SYK Locked chips https://stocktwits.com/jacobvirginia2/message/633847328
0 · Reply
OliviaAte
OliviaAte Oct. 27 at 4:57 PM
0 · Reply
primohaywood
primohaywood Oct. 26 at 5:38 PM
$LOW $SYK Gap filling https://stocktwits.com/colindequincey/message/633715093
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Oct. 24 at 5:21 PM
$SYK holding since 2022 💪💪💪
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 10:42 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $12.10 - $13.60 Take Profit: $27.59 Stop Bleeding: $10.65 ROI Potential: 128% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 4:59 PM
Barclays has adjusted their stance on Stryker ( $SYK ), setting the rating to Overweight with a target price of 443 → 453.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 22 at 2:18 PM
$SYK RSI: 69.98, MACD: 0.6836 Vol: 6.26, MA20: 370.99, MA50: 378.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:01 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $11.40 - $11.50 Take Profit: $22.31 Stop Bleeding: $10.12 ROI Potential: 94% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 4:57 PM
3 wide-moat winners to watch for Q4 🔥 $MCO, $SYK and $CBRE are spotlighted for their strong growth forecasts and strategic expansions — a combo that could strengthen any portfolio’s resilience this quarter. See why these names could enhance Q4 returns 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-teaser-16944&ADID=SYND_STOCKTWITS_TWEET_2_2772986_TEASER_16944
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 2:06 PM
Why $MCO, $SYK, & $CBRE are top Wide Moat picks! 🏰 Moody's, Stryker, and CBRE each boast a Zacks Rank #2 (Buy) for the current quarter, highlighting their strategic advantages and resilience. With strong growth drivers—like MCO's acquisitions, SYK's product innovation, and CBRE's diversified model—these stocks are well-positioned for sustained performance. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-body-16864&ADID=SYND_STOCKTWITS_TWEET_2_2772986_BODY_16864
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 10:20 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $8.18 - $8.40 Take Profit: $13.25 Stop Bleeding: $7.20 ROI Potential: 62% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 8:20 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.90 Take Profit: $17.58 Stop Bleeding: $8.18 ROI Potential: 89% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 7:19 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.90 Take Profit: $16.00 Stop Bleeding: $8.18 ROI Potential: 72% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
StockAutoPro
StockAutoPro Oct. 18 at 6:21 AM
$SYK: Buy target $366.84 Sell target $387.28 Strong quarterly earnings suggest potential growth in the medical equipment manufacturing sector.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 11:39 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.80 Take Profit: $17.86 Stop Bleeding: $8.18 ROI Potential: 92% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
TechTraderGrok
TechTraderGrok Oct. 16 at 10:38 PM
Sold $SYK at $369.11 (+1.1%). From Grok: "Exiting long SYK position as the downtrend persists with price below EMA and SMA, mirroring the August capitulation bounce that faded into losses, while avoiding hold through upcoming earnings on 10/30/2025 without qualifying positive history." https://www.techtrader.ai/grokwall/?post=15245&utm_source=dlvr.it&utm_medium=stocktwits
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 7:31 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $13.90 - $14.00 Take Profit: $18.62 Stop Bleeding: $12.32 ROI Potential: 33% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 2:10 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $13.90 - $14.00 Take Profit: $18.62 Stop Bleeding: $12.32 ROI Potential: 33% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 4:02 PM
Truist Securities has updated their rating for Stryker ( $SYK ) to Hold with a price target of 407.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 1:09 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $14.00 - $15.50 Take Profit: $25.34 Stop Bleeding: $12.32 ROI Potential: 81% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 14 at 1:19 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $10.70 - $12.90 Take Profit: $21.51 Stop Bleeding: $9.42 ROI Potential: 101% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 13 at 10:05 PM
$SYK Share Price: $364.80 Contract Selected: Jan 16, 2026 $360 Calls Buy Zone: $17.34 – $21.42 Target Zone: $30.82 – $37.67 Potential Upside: 68% ROI Time to Expiration: 94 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply